These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study. Bamberger EE, Ben-Shimol S, Abu Raya B, Katz A, Givon-Lavi N, Dagan R, Srugo I, Israeli Pediatric Bacteremia and Meningitis Group. Pediatr Infect Dis J; 2014 May; 33(5):477-81. PubMed ID: 24445822 [Abstract] [Full Text] [Related]
11. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group. Dagan R, Fraser D, Greif Z, Keller N, Kaufstein M, Shazberg G, Schlesinger M. Pediatr Infect Dis J; 1998 Sep 26; 17(9 Suppl):S198-203. PubMed ID: 9781763 [Abstract] [Full Text] [Related]
13. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction. Sigaúque B, Vubil D, Sozinho A, Quintó L, Morais L, Sacoor C, Carvalho MG, Verani JR, Alonso PL, Roca A. J Pediatr; 2013 Jul 26; 163(1 Suppl):S19-24. PubMed ID: 23773589 [Abstract] [Full Text] [Related]
14. Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study. Hammitt LL, Crane RJ, Karani A, Mutuku A, Morpeth SC, Burbidge P, Goldblatt D, Kamau T, Sharif S, Mturi N, Scott JA. Lancet Glob Health; 2016 Mar 26; 4(3):e185-94. PubMed ID: 26853149 [Abstract] [Full Text] [Related]
16. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001. McConnell A, Tan B, Scheifele D, Halperin S, Vaudry W, Law B, Embree J, of The Canadian Immunization Monitoring Program, ACTive (IMPACT). Pediatr Infect Dis J; 2007 Nov 26; 26(11):1025-31. PubMed ID: 17984810 [Abstract] [Full Text] [Related]
17. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Wenger JD. Pediatr Infect Dis J; 1998 Sep 26; 17(9 Suppl):S132-6. PubMed ID: 9781746 [Abstract] [Full Text] [Related]
18. Changing socioeconomic risk factors for invasive H. influenzae disease after the introduction of conjugate vaccine. Olowokure B, Spencer NJ, Hawker JI, Blair I, Smith RL. J Infect; 2003 Jan 26; 46(1):46-8. PubMed ID: 12504608 [Abstract] [Full Text] [Related]
19. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J. Pediatr Infect Dis J; 2001 Aug 26; 20(8):767-74. PubMed ID: 11734739 [Abstract] [Full Text] [Related]
20. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. Sow SO, Diallo S, Campbell JD, Tapia MD, Keita T, Keita MM, Murray P, Kotloff KL, Levine MM. Pediatr Infect Dis J; 2005 Jun 26; 24(6):533-7. PubMed ID: 15933564 [Abstract] [Full Text] [Related] Page: [Next] [New Search]